Clinical Trial · NCT04983459

PSMA PET/CT for Biochemical Recurrence Detection in Patients With Prostate Cancer

Overview

The aim of this study is to evaluate PSMA-PET for the detection of occult biological recurrence in patients with prostatic cancer referred to the Brest University Hospital.

Sponsor

University Hospital, Brest

ClinicalTrials.gov

NCT04983459

Eligibility

Inclusion

  • Patients referred for a PSMA PET/CT for biochemical recurrence in the nuclear medicine department of Brest University Hospital

Exclusion

  • Patients for whom PET-PSMA was performed for other reasons.
  • Patient's refusal to have their data used for clinical research purposes